Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederglobenewswire.com
GlobeNewswire - Industry News on Biotechnology
Get the latest updates from GlobeNewswire - Industry News on Biotechnology directly as they happen.
Follow now 73 followers
Latest posts
Last updated about 14 hours ago
4DMT Announces Accelerated 4D-150 Phase 3 Development in Wet AMD and Streamlined Organization to Drive Late-Stage Execution
about 14 hours ago
EMERYVILLE, Calif., July 02, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq...
Dyne Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares
about 14 hours ago
WALTHAM, Mass., July 02, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq:DYN)...
Informations relatives au nombre total de droits de vote et d’actions composant le capital
about 18 hours ago
Informations relatives au nombre total de droits de vote et d’actions composant...
I-Mab Presents Positive Givastomig Phase 1b Dose Escalation Data in Combination with Immunochemotherapy in Patients with 1L Gastric Cancers at ESMO GI 2025
about 19 hours ago
Data show confirmed ORR of 83% (10/12) at doses selected for ongoing...
Windtree Announces Issuance of Istaroxime Patent for the United States for Acute Heart Failure
about 21 hours ago
1.3 million patients are hospitalized annually in the U.S. from acute heart...
InFoods IBS receives CPT® Proprietary Laboratory Analysis (PLA) Code
about 22 hours ago
IRVINE, Calif., July 02, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA)...
Pneumagen Announces Peer-Reviewed Publication of Positive Phase II Study Data Highlighting the Potential of Neumifil, a Novel Broad-Spectrum Antiviral
about 22 hours ago
St Andrews, UK – 2 July 2025 - Pneumagen, a clinical stage...
Eyenovia Announces Rebranding and Corporate Name Change to Hyperion DeFi, Inc.
about 22 hours ago
Name change reflects company’s leadership position with its cryptocurrency treasury reserve strategy...
VYNE Therapeutics Provides Program Update on Oral BET inhibitor VYN202
about 22 hours ago
BRIDGEWATER, N.J., July 02, 2025 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq...
Abeona Therapeutics® Closes Sale of Rare Pediatric Disease Priority Review Voucher for $155 Million
about 22 hours ago
Cash resources totaled approximately $225 million as of June 30, 2025 Cash...
Shattuck Labs Announces Participation in Upcoming Leerink Partners Therapeutics Forum: I&I and Metabolism
about 23 hours ago
AUSTIN, TX and DURHAM, NC, July 02, 2025 (GLOBE NEWSWIRE) -- Shattuck...
Pelthos Therapeutics Completes Merger with Channel Therapeutics and Closes $50.1 Million Private Placement
about 23 hours ago
The combined company plans to launch ZELSUVMI™ for the treatment of molluscum...